Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 3
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England.
Kilcoyne A, Jordan E, Thomas K, Pepper AN, Zhou A, Chappell D, Amarapala M, Thériault RK, Thompson M. Kilcoyne A, et al. Among authors: theriault rk. Clinicoecon Outcomes Res. 2022 Apr 14;14:231-247. doi: 10.2147/CEOR.S360741. eCollection 2022. Clinicoecon Outcomes Res. 2022. PMID: 35444434 Free PMC article.